DC
AQST icon

Diametric Capital’s Aquestive Therapeutics AQST Stock Holding History

Diametric Capital’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.39M Buy
335,443
+206,967
+161% +$840K 0.36% 61
2025
Q4 		$830K Sell
128,476
-10,596
-8% -$66K 0.22% 118
2025
Q3 		$777K Sell
139,072
-26,301
-16% -$114K 0.29% 80
2025
Q2 		$547K Buy
+165,373
New +$474K 0.29% 97
2025
Q1 		– Sell
-35,295
Closed -$126K – 227
2024
Q4 		$126K Sell
35,295
-10,035
-22% -$46.3K 0.08% 263
2024
Q3 		$226K Sell
45,330
-197,382
-81% -$768K 0.11% 281
2024
Q2 		$631K Buy
242,712
+174,624
+256% +$583K 0.34% 74
2024
Q1 		$290K Buy
+68,088
New +$227K 0.16% 168

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $50.9B AUM 42.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return